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Persistent cancer-related fatigue (PCRF) is a symptom experienced by many cancer survivors. Acupressure oﬀers a potential
treatment for PCRF. We investigated if acupressure treatments with opposing actions would result in diﬀerential eﬀects on fatigue
and examined the eﬀect of diﬀerent “doses” of acupressure on fatigue. We performed a trial of acupressure in cancer survivors
experiencing moderate to severe PCRF. Participants were randomized to one of three treatment groups: relaxation acupressure
(RA), high-dose stimulatory acupressure (HIS), and low-dose stimulatory acupressure (LIS). Participants performed acupressure
for 12-weeks. Change in fatigue as measured by the Brief Fatigue Inventory (BFI) was our primary outcome. Secondary outcomes
were assessment of blinding and compliance to treatment. Fatigue was signiﬁcantly reduced across all treatment groups (mean ±
SD reduction inBFI:RA 4.0±1.5, HIS2.2±1.6, LIS 2.7±2.2), with signiﬁcantly greater reductions in the RA group. In an adjusted
analysis, RA resulted in signiﬁcantly less fatigue after controlling for age, cancer type, cancer stage, and cancer treatments. Self-
administered RA caused greater reductions in fatigue compared to either HIS or LIS. The magnitude of the reduction in fatigue
was clinically relevant and could represent a viable alternative for cancer survivors with PCRF.
1.Introduction
Persistent cancer-related fatigue (PCRF), deﬁned as an
unusual, constant, subjective sense of tiredness that is not
relieved by rest [1], is one of the most common symptoms
experienced by cancer survivors and it is often under-
diagnosed and often not treated [2]. Rates of signiﬁcant
PCRF in cancer patients range from 30% to 82% within
the ﬁrst ﬁve years of diagnosis [3] and as high as 34%
ﬁve to 10 years after diagnosis [3]. PCRF is associated with
decreased quality of life [4–6], decreased sleep quality and/or
quantity [5, 6], depression [7], and impaired cognition [8].
Beyond quality of life, subjective reports of low levels of
fatigue at diagnosis in breast cancer survivors, for example,
predict longer recurrence-free and overall survival even after
adjustingforkeyclinicalandsociodemographicconfounders
[9]. There are few treatment options for PCRF once clear
causes for fatigue are identiﬁed, for example, anemia. Cur-
rent treatment options require the availability of a trained
practitioner and are also associated with signiﬁcant costs
[10], signiﬁcant motivation on the part of the patient [10],
or have unacceptable side-eﬀects [11]. Consequently, low
toxicity,inexpensive,andnotdiﬃculttoperformtreatments,
which require minimal instruction by clinic staﬀ would be
useful alternatives for treating PCRF. Acupressure, which
possesses most of these qualities, could prove a useful
treatment for PCRF.
Acupressure is a technique derived from acupuncture, a
component of Traditional Chinese Medicine (TCM). During
acupressure physical force is applied to acupuncture points
by the hand, elbow, or with various devices in an eﬀort
to treat disease and reduce symptoms. Acupressure has
demonstrated positive eﬀects on sleep quality [12, 13], sleep
quantity [14, 15], and depression [15] in cancer patients
and other chronically ill populations. Pilot clinical trials
have also demonstrated that acupressure and acupuncture
can signiﬁcantly decrease persistent cancer fatigue by as
much as 38% [16], although sham acupressure also resulted2 Evidence-Based Complementary and Alternative Medicine
in similar decreases [16–19]. However, acupuncture in
contrast to acupressure can be expensive and requires the
availability of a trained professional making it unavailable
to some patients. In addition, there is a limit to how many
acupressure sessions a person can receive in a given period
of time such as a week. This, in turn, limits the “dose” of
acupuncture that can be administered. However, patients
can administer acupressure on a daily or even several times
daily basis without additional cost or need to travel to a
practitioner. Despite the potential advantages of acupressure
over acupuncture only one previous study has examined
acupressureforPCRF[17]andthisstudywasonlyconducted
for two weeks, which may not be enough time to observe
clinically signiﬁcant decreases in fatigue [16, 18, 19]. Also,
no previous trials have investigated the eﬀect of dose of
treatment on fatigue making it unclear how many weeks,
sessions per week, duration of sessions, and so forth, are
needed to achieve reductions in fatigue. Thus, we designed a
pilot study to examine the eﬀect of longer-term acupressure
and how the dose of acupressure impacted PCRF.
Speciﬁcally, the purpose of the study was to examine
two factors in acupressure treatment: dose and treatment
formula. For the former, we examined the eﬀect of 12 weeks
of high (HIS) and low (LIS) doses of self-administered
stimulating acupressure. For the latter, we compared these
two treatment formulas to self-administered relaxation acu-
pressure (RA). Treatment eﬀects were assessed by changes
in the severity of chronic fatigue in people diagnosed with
cancer who had completed all cancer therapies and who were
apparently cancer-free. We hypothesized that the stimulating
acupressuretreatments(HISandLIS)wouldpotentiallyhave
opposing actions on fatigue when compared to RA. This
could occur if the magnitude of the placebo eﬀect was
equal in all groups thus allowing for diﬀerences in treatment
formula to become more apparent. Our previous trial using
acupressure to modulate alertness in the classroom served as
the basis for this study design [20]. Moreover, we reasoned
that the high-dose treatment would be more eﬀective in
decreasing fatigue compared to the lower-dose treatment.
Secondary objectives were to evaluate the safety, tolerability,
adherence, blinding, and beliefs/expectation of participants
of the three acupressure treatments.
2.MaterialsandMethods
2.1. Participants and Eligibility. The study protocol and all
procedures were approved by the University of Michigan
Medical School Institutional Review Board and was con-
sidered HIPPA compliant. All participants provided written
informed consent. People aged 18 years of age and older
with a diagnosis of cancer (except for squamous and basal
cell carcinomas) who had completed their cancer-related
treatments at least 12 weeks prior (except for on-going hor-
mone therapy, which must have been initiated at least three
weeks prior to enrollment), were eligible for enrollment.
Participants had to have a complaint of persistent, moderate
to severe fatigue despite standard treatment (deﬁned as ≥4
on the Brief Fatigue Inventory (BFI)), maintain their typical
dietary patterns, especially the use of caﬀeinated beverages
throughout the study, be disease-free, and be acupuncture
and acupressure na¨ ıve, to be deemed eligible for the study.
Potential participants were deemed ineligible if they
were diagnosed with anemia (deﬁned as hemoglobin levels
<12gm/dL) or receiving treatment for anemia, had any
comorbidities likely to cause signiﬁcant fatigue (e.g., moder-
ate to severe heart failure, hypothyroidism) either currently
or before cancer diagnosis, had problems with easy or
spontaneous bruising from any cause, for example, bleeding
disorders, had nutritional deﬁciencies (deﬁned by albumin
levels <35g/liter), had a diagnosis of depression and were
not receiving active successful treatment for depression or
had a HADS depression score of ≥11, had a thyroid disorder
(deﬁned as either thyroid stimulating hormone or free T4
lower than the normal range or greater than 2 × s the
upper range), had an anticipated survival rate of less than
six months, had an initiation, a cessation or change of dose
(up to three weeks prior to the study’s start) of any chronic
medications or dietary supplements or any planned change
of chronic medications or dietary supplements during the
study, and were pregnant or lactating.
2.2. Objectives and Outcomes. This was a pilot clinical
study where our primary objective was to test the eﬀect of
two intensities of self-administered stimulating acupressure
compared to relaxation acupressure on severity of fatigue at
12 weeks as determined by the BFI. The BFI is a validated
measure developed at the MD Anderson Cancer Center
to screen cancer patients for fatigue. The BFI assesses the
severity of and the impact of fatigue on daily functioning in
patients with cancer [21]. The BFI is an average of 10 ques-
tions where “0” is considered no fatigue or impact on func-
tioning and “10” represents the “worst imaginable fatigue”
or “completely interfered” with their daily functioning.
The secondary objectives included: (1) participants com-
pliance to treatment as measured by daily treatment logs
[22]; (2) beliefs and expectations of acupressure treatment
assessed by questionnaire; (3) safety and tolerability of
acupressure treatments determined by reports of adverse
events reported and graded per NCI Common Terminology
Criteria for Adverse Events (CTCAEs) version 3.0; (4)
assessment of blinding, during the 12 week study period.
2.3. Randomization, Blinding, and Allocation. Eligible par-
ticipants were randomized equally to high-dose stimulating
acupressure (HIS), low-dose stimulating acupressure (LIS),
or relaxation acupressure (RA) groups. The randomization
code was computer-generated, and stratiﬁed by the three
study acupressure practitioners, by the study biostatistician.
The randomization list was given to the project manager
who had no contact with study participants. For each new
participant the project manager chose the next sequential
randomization number and linked that with the indicated
acupressuretreatmentandpractitioner.Theprojectmanager
then informed the indicated acupressure practitioner which
acupressure treatment to teach to the participant. All study
participants as well as all study personnel who assessedEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Acupressure point locations. HIS and LIS speciﬁc point locations in black: Conception Vessel 6 (CV6), Large Intestine 4 (LI4),
Stomach 36 (St36), Kidney 3 (K3), and Si Shen Chong. RA speciﬁc point locations in red: Heart 7 (Ht7), Liver 3 (Liv3), Anmian, and Yin
Tang. Common point for all groups HIS, LIS, and RA in gray: Spleen 6 (Sp6).
outcomes, worked with study data, or administered tests or
questionnaires were unaware of the randomization list or
treatment assignment except for the project manager and the
acupressure practitioners. Participants and study personnel,
excepttheacupressurepractitionersandtheprojectmanager,
were blinded to study assignments.
2.4. Recruitment and Screening. Potential participants were
identiﬁed and referred to us by their oncologist or through
the referral of a nurse practitioner that ran a gynecological
cancer support group. Participants presented for a screen-
ing visit where a history, physical, screening blood work,
concomitantmedications,andscreeningquestionnaires(BFI
and Hospital Anxiety and Depression Scale {HADS})w e r e
obtained. Participants then returned to the study clinic for
a baseline visit, within 60 days of the screening visit. At the
baselinevisiteligiblesubjectswererandomlyassignedtoself-
administer either HIS, LIS, or RA for 12 weeks. Participants
in the HIS and RA groups self-administered acupressure for
30 (HIS) or 27 (RA) minutes, respectively, twice per day. The
LIS arm was asked to administer acupressure to themselves
three times per week for 30 minutes per day.
2.5. Intervention. The LIS and HIS acupressure points were
identical and consisted of Stomach 36 ({ST36} bilaterally),
Spleen 6 ({SP6} bilaterally), Kidney 3 ({KI3} bilaterally),
Large intestine 4 ({LI4} bilaterally), Conception vessel 6
(CV6), and Governing vessel 20 (GV20). The relaxation acu-
pressure points consisted of Yin Tang, Anmian (bilaterally),
Heart 7 ({HT7} bilaterally), Liver 3 ({LIV3} bilaterally), and
Spleen 6 (bilaterally) (see Figure 1). For all three acupressure
arms, participants were instructed to make small clockwise
circles with their index ﬁnger, thumb, or a pencil eraser
to stimulate the points for three minutes per point, with
suﬃcientpressuretoevokea“deqi”sensation(i.e.,dullache,
tingling, and soreness). Participants were given hands on
instructions from one of the three acupressure practitioners
at the baseline visit concerning correct pressure and place-
ment of acupressure points. They were also given a diagram
with written instructions of the points and a timer to ensure
that points were stimulated for the full three minutes. Of
note, our protocol used the same amount of pressure (i.e.,
that required to elicit “de qi”) for all three groups RA, HIS,
andLIS.Therewasnodiﬀerenceinpressureintensitiesacross
ourthreestudygroups.HISandLISwerediﬀerentonlyinthe
number ofacupressuresessionsperweek andnot diﬀerent in
the intensity of pressure applied at acupuncture points. All
participants were asked weekly via phone calls and/or emails
if they needed assistance ﬁnding any points and encouraged
to come back in for retraining if necessary.
Acupressure points were chosen by consensus of the
ﬁve acupressure practitioners and based on a previous4 Evidence-Based Complementary and Alternative Medicine
research study examining acupressure for sleepiness [20].
Practitioners had to have been in practice for at least two
years actively seeing patients. The acupressure practitioners
h a dr e c e i v e dd i ﬀerent degrees qualifying them to practice
acupressure including a Naturopathic Doctorate (ND), a
Masters in TCM or Oriental Medicine and a License of
Acupuncture (L.Ac.), or a Diploma in Acupuncture (Dipl.
Ac.). Practitioners were asked to choose a set of relaxing
points based on a formula to treat insomnia and stimulating
acupressure points based on a Western diagnosis of fatigue
that could be reasonably reached by participants, that is, not
the middle of the back, and not so many points that it would
take an excessive amount of time to complete a treatment.
Participants’beliefsandexpectationsofacupressurewere
collected at baseline and at week 12 using a questionnaire. At
baseline we asked six questions: (1) What is your impression
of acupressure [22]; How much do you want acupressure
to reduce your fatigue; (2) how conﬁdent are your that
applying acupressure to your body will alleviate fatigue; (3)
how conﬁdent are you in correctly applying acupressure;
(4) How successful do you think this treatment would be
in alleviating other complaints you may be experiencing;
(5) how conﬁdent would you be in recommending this
treatment to a friend suﬀering from similar complaints.
Similarlyatweek12weaskedﬁverelatedquestions:(1)What
is your impression of acupressure [22]; How conﬁdent are
your that applying acupressure to your body did alleviate
f a t i g u e ;( 2 )H o wc o n ﬁ d e n ta r ey o ut h a ty o ua r ec o r r e c t l y
applying acupressure; (3) How successful was this treatment
in alleviating other complaints you may be experiencing; (4)
How conﬁdent are you in recommending this treatment to a
friend suﬀering from similar complaints. All questions were
answered with a 7-point Lickert scale ranging from, “Not
at all Conﬁdent or Successful” to “Extremely Conﬁdent or
Successful.”
Participants also came for a ﬁnal visit 12 weeks after
the baseline appointment where a ﬁnal BFI, assessment of
blinding, and measurement of beliefs and expectations of
acupressure were held. Participants were also contacted by
email or phone once weekly between the baseline and the
ﬁnal week 12 visit, to enquire about adverse events and to
collect BFIs.
2.6. Statistical Methods and Sample Size. Baseline charac-
teristics are reported, stratiﬁed by treatment group, using
means and SDs for continuous variables, and counts and
percentages for categorical variables. Balance between treat-
ment groups on baseline characteristics was tested using
independent samples t-tests for continuous variables and
Fisher exact tests for categorical variables. For continuous
variables,theassumptionofnormalitywascheckedusingthe
Shapiro-Wilks test. To investigate a change from baseline in
theBFIscore,amixedmodelanalysiswascalculatedwithBFI
as the dependent variable and acupressure treatment group,
age, type of cancer, stage of cancer, received chemotherapy,
received radiation, and week as covariates.
For examining the group diﬀerences in categorical vari-
ables including adverse events, assessment of blinding and
beliefs and expectations of acupressure Pearson χ2 or Fisher
exact tests were performed, as appropriate. The association
between adherence to treatment in minutes, derived from
the daily study log, and change in BFI were calculated using
bivariate correlations. Analyses were conducted according to
the intention-to-treat principle; however, no imputation was
performedformissingvaluesatanyofthetimepointsforthe
BFI score. Data were entered into SPSS Windows version 17
(SPSS, Chicago, IL) and analyzed using SAS version 9. (Cary,
NC: SAS Institute Inc.). For all analyses, two-sided tests and
a signiﬁcance level of 0.05 were used.
We selected a reduction of 3.1 points on the BFI
(31.1%[95% CI, 20.6% to 41.5%], improvement) as a
clinically meaningful improvement in fatigue severity, based
on changes observed in previous acupuncture studies using
the BFI to assess diﬀerences in cancer fatigue [16]. The
study was therefore designed to have 80% power assuming
a two-sided alpha level of 0.05 and n = 15 participants per
treatment group.
3. Results
3.1. Participants and Toxicity. We screened 505 people
between August, 2008, and April, 2009. Of the 505 people
screened, 357 were determined to be ineligible, 148 were
potentially eligible but did not complete screening, and
43 met all eligibility criteria and were randomized: 15
to HIS acupressure, 14 to LIS acupressure, and 14 to RA
acupressure, for 12 weeks. Figure 2 documents numbers
of participants, reasons for exclusions, and reasons for
discontinuing the intervention. There was no signiﬁcant
diﬀerence between treatment groups for any demographic
or clinical characteristic (Table 1). All of the participants
but one were women (N = 42, 97.6%) with mean age of
54.0 ± 9.0 (range 31–74 years). Over 90% of participants
indicated they were Caucasian (N = 40, 93.0%) and none
of the participant reported being of Hispanic ethnicity. All
related toxicities are shown in Table 2. No toxicities greater
than NCI Common Toxicity Criteria (v. 3.0) Grade 1 were
reported [16, 23]. There was no diﬀerence between the
groups in terms of total adverse events (P = .45) or speciﬁc
types of adverse events such as musculoskeletal toxicities
(P = .64). No participants asked for further clariﬁcation or
trainingtolocateand/oradministertheiracupressurepoints.
3.2. Change in Fatigue. The change in severity of fatigue
as assessed by the BFI was signiﬁcantly diﬀerent across
treatment groups, with greater reductions in the relaxation
acupressuregroup(seeFigures3and4;mean±SDreduction
in BFI: RA 4.0 ± 1.5, HIS 2.2 ± 1.6, LIS 2.7 ± 2.2; P =
.027). These changes represent a mean decrease of fatigue
from baseline of 44.8 ± 35.9% in the HIS group, 49.5
± 35.2% in the LIS group and 70.5 ± 23.4% in the RA
group. In a linear regression model with the change in BFI
as the dependent variable, the group diﬀerence remained
signiﬁcant after adjusting for age, cancer type, cancer stage,
and cancer treatments with radiation, chemotherapy, and
surgery (P = .013).Evidence-Based Complementary and Alternative Medicine 5
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intensity stimulatory acupressure
2Individual non-completers may not equal total for non-completers because some participants had
multiple reasons for going off-study
3 Non-completers2
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Figure 2: CONSORT diagram of ﬂow of participants through the clinical trial.
The majority of the change in BFI was observed during
the ﬁrst four weeks of acupressure treatment regardless of
study group (Figure 3). The mean BFI (all groups) was 5.8
at baseline decreasing to 3.5 at week 4, a 3.3 point drop.
The decrease in BFI between weeks 4 to 12 was only 0.9
points from 3.5 to 2.6. Similar patterns were observed in the
separate study arms with participants who were randomized
to HIS observing a mean decrease of BFI from 4.6 to 3.3;
LIS 5.3 to 3.5; RA 5.8 to 2.3, between baseline and week 4.
Notably, the small additional decrease in BFI was observed
between weeks 4 and 7, while after week 7 mean BFI stayed
approximately the same until the end of the study (see
Figure 3).
We deﬁned a responder to acupressure as a person who
experiences at least a 31% (based on a 3.1 point decrease on
the BFI being considered clinically signiﬁcant) decrease in
fatigue from baseline. Although not statistically signiﬁcant
(P = .155), there was a tendency for the study participants in
the RA group to be responders (92.9%, n = 13), compared
to participants in the LIS (66.7%, n = 10) or HIS groups
(64.3%, n = 9).
3.3. Blinding and Adherence. Participants were blinded to
their acupressure treatment group (P = .6 2 ) .H o w e v e r ,i n
contrast to blinding, there were diﬀerences in adherence
between the three treatment groups. There was a trend for6 Evidence-Based Complementary and Alternative Medicine
Table 1: Baseline characteristics.
Relaxation acupressure (n = 14) Low-intensity acupressure
(n = 14)
High-intensity acupressure
(n = 15)
Demographics
Sex n(%)
Women 14 (100.0) 13 (93.0) 15 (100.0)
Men 0 (0.0) 1 (7.0) 0 (0.0)
Age (mean years) ± SD 51.5 ± 6.7 54.4 ± 10.0 56.0 ± 9.3
Race n(%)
White 12 (86.0) 13 (93.0) 15 (100.0)
Clinical characteristics
BFI at baseline (mean ± SD)
a 5.8 ± 1.2 5.3 ± 1.7 4.4 ± 2.0
Conﬁdence in acupressureb 9 (64) 4 (29) 4 (27)
Cancer type n(%)
c
Breast 8 (57.0) 7 (50.0) 9 (60.0)
Uterine 1 (7.0) 2 (14.3) 1 (6.7)
Cervical 1 (7.0) 1 (7.1) 0 (0.0)
Endometrial 3 (2.0) 1 (7.1) 1 (6.7)
Ovarian 1 (7.0) 1 (7.1) 4 (26.6)
Otherd 1 (7.0) 2 (14.1) 0 (0.0)
Stage of cancer n (%)
c
Stage 1 9 (64.3) 8 (57.1) 8 (53.0)
Stage 2 4 (28.6) 3 (21.4) 3 (20.0)
Stage 3 0 (0.0) 1 (7.1) 3 (20.0)
Stage 4 0 (0.0) 2 (14.3) 1 (7.0)
Unknown 1 (7.1) 0 (0.0) 0 (0.0)
Time since cancer diagnosis in
months (mean ± SD)
e 37.9 ± 35.3 36.4 ± 47.6 44.6 ± 49.2
Treatments (were received) n(%)
Surgery 14 (100.0) 13 (93.0) 15 (100.0)
Chemotherapy 7 (50.0) 7 (50.0) 10 (67.0)
Radiation 8 (57.0) 10 (71.0) 10 (67.0)
Immunotherapy 0 (0.0) 0 (0.0) 1 (7.0)
Other 0 (0.0) 1 (7.0) 2 (13.0)
aBFI: Brief Fatigue Inventory.
bWhat percentage of participants were at least moderately conﬁdent that acupressure would alleviate their fatigue at the baseline visit.
cPercentages may not add up to 100% because participants can receive multiple treatments or diagnoses.
dMelanoma, colorectal, unknown primary.
e“Time since Cancer Diagnosis” was calculated from on-study date and date of diagnosis in months.
LIS participants (who were asked to do acupressure only
three times weekly versus seven times weekly in the RA
and HIS groups) to perform a greater percentage of their
treatments compared to either the RA or HIS groups (mean
± SD: LIS 82 ± 30%, RA 70 ± 23%, HIS 50 ± 35%; P = .08).
Further, across all groups, greater time spent performing
acupressure was associated with greater reductions in fatigue
(r =− 0.39; P = .037).
3.4. Beliefs and Expectations. Across all groups, there was
no signiﬁcant relationship between the belief and expecta-
tion that acupressure would help alleviate fatigue and the
reduction in BFI at week 12 from baseline for any of the six
questionsaskedonthebaselinesurvey(P valuesrangedfrom
0.22 to 0.98). The baseline measure of conﬁdence of acu-
pressure in alleviating fatigue was not diﬀerent across groups
(P = .10). Most participants were moderately conﬁdent thatEvidence-Based Complementary and Alternative Medicine 7
Table 2: Adverse events by person.
N (%)
Adverse events RA
(n = 14)
LIS
(n = 14)
HIS
(n = 15) P-valuea
Participants with any
adverse events 5 (36) 0 (0) 4 (27) 0.45
Musculoskeletalb 3 (21) 0 (0) 3 (20) 0.64
Otherc 2 (14) 0 (0) 1 (7) 0.64
aP-values were calculated using Pearson chi-square test.
bMusculoskeletal Symptoms include: leg cramps, hand cramps, achiness,
osteoarthritis diagnosis, tenderness, and mild bruising.
cOther includes: dizziness, hot ﬂashes, and transient sleep issues.
All adverse events were given a grade 1 on the Common Terminology
Criteria for Adverse Events v3.0.
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Figure 3: Self-administered relaxation acupressure reduces persis-
tent cancer fatigue. A plot of mean weekly fatigue scores for RA (red
circles), HIS (closed black circles), and LIS (open circles) across
study weeks demonstrates that RA evokes greater reductions in
fatigue scores compared to HIS and LIS.
applying acupressure would alleviate their fatigue (RA =
64%; LIS = 29%; HIS = 27%). In a general linear model
across groups, with week 12BFI as the dependent variable
and week 0BFI as a covariate, conﬁdence in acupuncture
alleviating fatigue trended towards signiﬁcance (P = .08). At
week 12 across groups, there was no signiﬁcant relationship
between conﬁdence in acupressure in alleviating fatigue and
actual changes in BFI (P = .47).
3.5. Discussion. Self-administered relaxation acupressure
causedgreaterreductionsinfatiguewhencomparedtoeither
high- or low-dose stimulatory acupressure. This eﬀect was
not modiﬁed by relevant clinical or demographic variables.
Across groups, these reductions in fatigue were on the order
of 45% to 70%, which were clinically relevant and could
represent signiﬁcant improvements in quality of life for
cancer survivors.
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Figure 4: Self-Administered Relaxation Acupressure Engenders
Greater Reductions in Fatigue than Stimulation Acupressure.
Scatter plot of individual participant BFI change scores (week 12—
week 0) indicate greater reductions for RA (red circles) than HIS
(closed black circles) and LIS (open circles).
We observed a much larger decrease in fatigue compared
to other studies examining acupuncture and/or acupres-
sure in cancer patients [16–19]. The largest decrease in
fatigue reported in other studies was 38% [16]c o m p a r e d
to our smallest decrease of 45% observed in the high
dose stimulatory acupressure group. Diﬀerences in study
population, length of study and duration/frequency of
acupressure treatments, acupoint locations, fatigue scales,
and use of acupuncture rather than acupressure could all be
reasons for the diﬀerence in fatigue reduction across studies.
Perhaps most obviously, three of the four studies examined
acupuncture [16, 18, 19] not acupressure to treat cancer-
relatedfatigue.Also,forinstance,whiletwostudiesexamined
cancer patients after the cessation of treatments [16, 17],
two other studies examined the eﬀect of acupuncture for
treating cancer fatigue during radiation treatments [18, 19].
In these later studies, the negative physiological eﬀects of
ongoingradiationmayaccountforthelesspronouncedeﬀect
ofacupressureonreducingfatiguecomparedtopatientswho
have completed treatment.
Another reason we may have observed a greater reduc-
tion in fatigue is duration and/or frequency of the acupres-
sure treatment. In three of the previous studies examining
acupuncture for fatigue in cancer patients [16, 18, 19],
participants received acupuncture one to two times per
week for six weeks, while, in another study, participants
received six sessions of acupressure or acupuncture over
two weeks [17]. The largest decreases in fatigue of 36%
to 38% [16, 17], were observed when 12 to 24 sessions
of acupuncture were administered whether over two weeks
or six weeks, while only a 19% reduction in fatigue was
observed when acupressure was self-administered daily for
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[17]. Less pronounced eﬀects on fatigue in these studies
compared to ours may be due to both the increased duration
and frequency of acupressure treatments in our study. We
observed that at least four weeks were needed to achieve
signiﬁcant eﬀects and seven weeks of treatment to reach
am a x i m u me ﬀect. Thus, to have the maximum eﬀect on
fatigue participants in our study, needed to perform a
minimum of 21 to 49 acupressure treatments over seven
weeks (three times per week to one time per day, depending
on study arm). In fact, we found that fatigue continued to
signiﬁcantly decrease the more acupressure was performed,
regardless of the study group.
Diﬀerences between our results and previous acupres-
sure/acupuncture trials for cancer fatigue could also be due
to diﬀerent fatigue measures. Only the study by Vickers et
al. used the BFI [16]. Other principal measures of fatigue
used in other studies include the Multidimensional Fatigue
Inventory (MFI) [17], the Lee Fatigue Scale [18], and the
Functional Assessment of Chronic Illness Therapy-Fatigue
Subscale (FACIT-F) [19]. All of these fatigue scales are able
to capture both physical and psychological aspects of fatigue
andareusefulforbothscreeningandoutcomeassessmentsin
fatigue trials [24]. However, neither the FACIT-F nor the Lee
fatiguescaleshavebeenvalidatedincancerpatientsandnone
of these measures have been tested for their convergence
or divergence from one another [24]. Lacking this data, it
is diﬃcult to make comparisons across measures, although
the BFI and MFI are constructed in a similar manner and
producedsimilarresultsforacupunctureacrossotherstudies
[16, 17].
Earlier studies enrolled samples that were potentially
more diverse than our study sample. For instance, in several
previous studies, there were signiﬁcantly more men [16–
18], older patients [16, 18], or participants having a wider
range of cancer diagnoses compared to our sample [16–18].
Smallerimprovements infatigueinthesestudies couldimply
that acupressure is more eﬀectivein certainpopulations such
as younger women. Consequently, the relative homogeneity
of our study sample of white women predominantly in their
50’s could be one where our participants responded more
favorably to acupressure than observed in other studies.
Finally, it is possible that the larger reduction in fatigue
we observed in our study is due to our choice of acupoints.
Active acupoints chosen in earlier studies [16–19]o v e r l a p
appreciablywiththeacupointswechoseforbothourLISand
HIS groups. Of the six points in our stimulating acupressure
groups, two previous trials used ﬁve of the same points
(ST36, SP6, KI3, LI4, and CV6) [16, 18, 19], one used
four of the same points (ST36, SP6, KI3, and CV6), and
one used three of the same points (ST36, SP6, and LI4)
[17,18].Incontrast,onlyonestudyincludedapointineither
their true or sham acupoints that overlapped with our RA
points (LIV3) with the exception of SP6 which we included
in both our stimulating and relaxation groups. This would
argue that there may be some speciﬁc eﬀect of the relaxation
acupoints on fatigue diﬀerent from or of a larger magnitude
than for the stimulating acupoints. One possible mechanism
for RA could be through improving sleep quality, as sleep
disturbances are positively correlated with persistent fatigue
and are a signiﬁcant predictor of persistent fatigue [25].
While we did not examine sleep parameters in this study, in
a separate study in fatigued college students [20], we showed
that participants were less alert and more sleepy following
relaxationcomparedtostimulatoryacupressure.Ofnote,the
acupointsusedinthatstudywerealmostidenticaltotheones
we used in the current study in cancer survivors. Further
investigation of how diﬀerent acupressure techniques may
diverge or converge in their aﬀect on sleep quality and other
key mechanisms of PCRF would help to clarify the speciﬁc
role of diﬀerent acupoints.
We also investigated the eﬀe c to fd o s eo fa c u p r e s s u r e
on fatigue. Very few studies have assessed the eﬀect of dose
on the eﬃcacy of acupuncture or acupressure treatments.
This has led researchers to posit that acupuncture studies
with null ﬁndings could be due to false negative results from
inadequate number, length, or duration of treatments, for
instance. At least two studies support the idea that fewer
sessionsperweekorshorterlengthofacupuncturetreatment
are not as eﬀective at decreasing pain. Harris et al. [21]
found that three acupuncture sessions weekly provided more
pain relief than one session weekly (P = .039). Another
research group [26] discovered that the diﬀerence between
sham and true acupuncture for pain was not evident at
eight weeks, but was statistically signiﬁcant at 14 weeks. We,
however, found no diﬀerence in fatigue between our high-
dose and low-dose stimulating treatments. This was despite
the low dose performing only three 30 minute sessions per
week compared to the high dose performing two 30 minute
sessions daily. Even when decreased adherence in the HIS
group was taken into account, the participants were still
consistently administering at least one 30 minute session
daily, which is appreciably more than the LIS group. Thus,
it would appear that the duration in weeks of acupressure,
not the frequency or the total number of treatments, were
of more importance for decreasing persistent fatigue. Future
studies could examine this question in more depth as well as
observing how long treatment eﬀects exist after patient stop
administering acupressure.
Self-administered acupressure was exceedingly safe and
well tolerated with only nine minor transitory adverse
events. Moreover, no participant stopped their acupressure
or withdrew from the study as a result of these eﬀects. The
acupressure treatments also appeared to be an acceptable
treatment for cancer survivors. However, it appears to be
neither feasible nor desirable to ask participants to perform
acupressure more than once daily. Participants randomized
to RA and HIS who were asked to perform acupressure twice
daily, were less compliant, and in general performed their
acupressure only once daily.
Except for one question, participants’ belief and expec-
tations of acupressure did not predict response to acupres-
sure treatment for PCRF. However, the question asked at
baseline about conﬁdence in acupuncture alleviating fatigue
approached statistical signiﬁcance (P = .08) for predicting
change in week 12 BFI. Also, while only approaching signif-
icance, more people who were randomized to the RA arm
indicated that they were conﬁdent in acupuncture alleviating
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(RA = 64%; LIS = 29%; HIS = 27%; P = .10). Conse-
quently, conﬁdence in acupressure could be an important
predictor and/or mediator of its ability to alleviate fatigue,
with those who are more conﬁdent receiving a larger beneﬁt
fromthetreatment.Otherstudiesexaminingpatients’expec-
tations of and conﬁdence in acupressure or acupuncture
show mixed results [24–29] with some studies showing a
signiﬁcant association between reduction in pain and conﬁ-
denceinacupressureand/oracupuncture[27–31]andothers
ﬁnding no association [32]. Unfortunately, acupressure and
acupuncture studies examining the eﬀect of belief and con-
ﬁdence in the treatments have focused largely on pain, not
fatigue, as an outcome. As such, it is diﬃcult to draw com-
parisons between our study’s results concerning belief and
expectations and other acupuncture or acupressure studies.
Clearly,thisisanareathatrequiresfurtherresearchintowhat
extent and how conﬁdence in acupressure aﬀects its eﬃcacy.
This study had several limitations. As this study was
conceived as a pilot and feasibility trial, we had only a
small sample size of 43 participants. Larger studies in cancer
survivors would be needed to conﬁrm and compare results
from this trial. Also, our study sample lacked variability with
the majority of participants being white women diagnosed
with breast, ovarian, or endometrial cancer. As such, the
results have limited generalizability. Further studies would
be needed to investigate the eﬀects of self-administered acu-
pressure for fatigue in other populations such as men, racial
or ethnic minorities, other cancer types, and in children.
This study also did not examine any mechanism by which
acupressure caused decreased fatigue. Future studies would
be needed to examine both behavioral and physiological
mechanisms to help better understand the full utility of
acupressure in the clinical setting.
Along with a greater eﬀect in reducing fatigue, acupres-
sure has several advantages over acupuncture treatments: it
can be self-administered with little eﬀort and time on the
part of the patient, it is well tolerated, of low-cost, and
requires minimal instruction by clinic staﬀ,f o re x a m p l e ,
a nurse. Patients with needle phobias and without severe
bleeding disorders or issues with bruising can still beneﬁt
from acupressure when acupuncture would be contraindi-
cated.
In summary, self-administered acupressure holds sig-
niﬁcant potential for being a cost-eﬀective, low-toxicity,
self-care treatment for PCRF, one of the most troubling
s y m p t o m sf o rc a n c e rs u r v i v o r s .F u r t h e rr e s e a r c hi sn e e d e d
to elucidate the mechanisms behind acupressure’s eﬀect on
fatigue. In particular, our research indicates that further
investigation should focus on the distinct role of the eﬀects
of speciﬁc acupoints and expectations of acupressure. Other
important areas for potential investigation include the role
of “dose” and speciﬁcally duration of acupressure treatment
and diﬀering eﬀects of acupressure in diverse populations.
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